Focus on Antibiotics – New Challenges and Steps Forward in Discovery and Development, 2nd Edition
This Special Issue, "Focus on Antibiotics – New Challenges and Steps Forward in Discovery and Development, 2nd Edition," explores innovative strategies and groundbreaking research to combat antibiotic resistance. Key advancements include enhancing antibacterial drug potency, selectivity, and safety...
Spremljeno u:
| Format: | Online |
|---|---|
| Jezik: | engleski |
| Izdano: |
MDPI - Multidisciplinary Digital Publishing Institute
2025
|
| Teme: | |
| Online pristup: | ONIX_20250812T110751_9783725840281_297 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
| _version_ | 1863732340358905856 |
|---|---|
| collection | Directory of Open Access Books |
| description | This Special Issue, "Focus on Antibiotics – New Challenges and Steps Forward in Discovery and Development, 2nd Edition," explores innovative strategies and groundbreaking research to combat antibiotic resistance. Key advancements include enhancing antibacterial drug potency, selectivity, and safety through five-membered heterocycles; using phytocannabinoids like cannabigerol for MRSA biofilm inhibition; employing ZnONPs and AuNPs to combat MDR pathogens; developing Bac10307-AgNPs with potent antibacterial and antioxidant properties; creating fluoroquinolone co-crystals with flavonoids for enhanced antimicrobial activity; synthesizing 6″-deoxykanamycin A analogues to improve activity against resistant Staphylococcus aureus; designing silver nanocomposites with significant antibacterial and antibiofilm activity; utilizing the insect AMP Tricoplusia ni cecropin A for colistin-resistant Escherichia coli with low cytotoxicity; and enhancing antimicrobial and antiviral activity with peptide [des-Cys11,Lys12,Lys13-(p-BthTX-I)2K] derivatives. This Special Issue showcases collaborative efforts to address antibiotic resistance, inspiring further research and development. |
| format | Online |
| id | doab-20.500.12854ir-165542 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2025 |
| publishDateRange | 2025 |
| publishDateSort | 2025 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1655422025-08-12T09:53:33Z Focus on Antibiotics – New Challenges and Steps Forward in Discovery and Development, 2nd Edition Rusu, Aura Uivarosi, Valentina bacteria L. acidophilus silver nanoparticles cancer bacteriocins TEM protein target antibiotic resistance bacterial pathogens ESBLs gold nanoparticles nano-therapeutics p-BthTX-I p-Bth multidrug-resistant bacteria antimicrobial peptide dendrimers PLpro SARS-CoV-2 COVID-19 antimicrobial resistance aminoglycosides kanamycin chemical modification mode of action translation inhibition thioureidophosphonates silver nanocomposites antibacterial bactericidal antifouling antibiofilm molecular docking colistin-resistant Escherichia coli lipopolysaccharide Trichoplusia ni cecropin bacterial resistance methicillin-resistant S. aureus (MRSA) multi drug resistant (MDR) bacteria Cannabis sativa phytocannabinoids (PCs) endocannabinois (ECs) synthetic cannabinoids (SCs) synthetic procedures cannabichromene (CBC) cannabigerol (CBG) cannabidiol (CBC) heterocycles five-membered heterocycles antibiotics antibacterials nitrogen heterocycles oxygen heterocycles sulfur heterocycles biological activity drug design drug discovery ZnONPs biosynthesis characterization antimicrobial applications antimicrobial mechanisms co-crystals crystal engineering flavonoids antimicrobials HP1043 essential transcription factor Helicobacter pylori thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general This Special Issue, "Focus on Antibiotics – New Challenges and Steps Forward in Discovery and Development, 2nd Edition," explores innovative strategies and groundbreaking research to combat antibiotic resistance. Key advancements include enhancing antibacterial drug potency, selectivity, and safety through five-membered heterocycles; using phytocannabinoids like cannabigerol for MRSA biofilm inhibition; employing ZnONPs and AuNPs to combat MDR pathogens; developing Bac10307-AgNPs with potent antibacterial and antioxidant properties; creating fluoroquinolone co-crystals with flavonoids for enhanced antimicrobial activity; synthesizing 6″-deoxykanamycin A analogues to improve activity against resistant Staphylococcus aureus; designing silver nanocomposites with significant antibacterial and antibiofilm activity; utilizing the insect AMP Tricoplusia ni cecropin A for colistin-resistant Escherichia coli with low cytotoxicity; and enhancing antimicrobial and antiviral activity with peptide [des-Cys11,Lys12,Lys13-(p-BthTX-I)2K] derivatives. This Special Issue showcases collaborative efforts to address antibiotic resistance, inspiring further research and development. 2025-08-12T09:53:31Z 2025-08-12T09:53:31Z 2025 book ONIX_20250812T110751_9783725840281_297 9783725840281 9783725840274 https://directory.doabooks.org/handle/20.500.12854/165542 eng image/jpeg Attribution 4.0 International https://mdpi.com/books https://mdpi.com/books/pdfview/book/10898 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-4027-4 10.3390/books978-3-7258-4027-4 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783725840281 9783725840274 282 open access |
| spellingShingle | bacteria L. acidophilus silver nanoparticles cancer bacteriocins TEM protein target antibiotic resistance bacterial pathogens ESBLs gold nanoparticles nano-therapeutics p-BthTX-I p-Bth multidrug-resistant bacteria antimicrobial peptide dendrimers PLpro SARS-CoV-2 COVID-19 antimicrobial resistance aminoglycosides kanamycin chemical modification mode of action translation inhibition thioureidophosphonates silver nanocomposites antibacterial bactericidal antifouling antibiofilm molecular docking colistin-resistant Escherichia coli lipopolysaccharide Trichoplusia ni cecropin bacterial resistance methicillin-resistant S. aureus (MRSA) multi drug resistant (MDR) bacteria Cannabis sativa phytocannabinoids (PCs) endocannabinois (ECs) synthetic cannabinoids (SCs) synthetic procedures cannabichromene (CBC) cannabigerol (CBG) cannabidiol (CBC) heterocycles five-membered heterocycles antibiotics antibacterials nitrogen heterocycles oxygen heterocycles sulfur heterocycles biological activity drug design drug discovery ZnONPs biosynthesis characterization antimicrobial applications antimicrobial mechanisms co-crystals crystal engineering flavonoids antimicrobials HP1043 essential transcription factor Helicobacter pylori thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general Focus on Antibiotics – New Challenges and Steps Forward in Discovery and Development, 2nd Edition |
| title | Focus on Antibiotics – New Challenges and Steps Forward in Discovery and Development, 2nd Edition |
| title_full | Focus on Antibiotics – New Challenges and Steps Forward in Discovery and Development, 2nd Edition |
| title_fullStr | Focus on Antibiotics – New Challenges and Steps Forward in Discovery and Development, 2nd Edition |
| title_full_unstemmed | Focus on Antibiotics – New Challenges and Steps Forward in Discovery and Development, 2nd Edition |
| title_short | Focus on Antibiotics – New Challenges and Steps Forward in Discovery and Development, 2nd Edition |
| title_sort | focus on antibiotics new challenges and steps forward in discovery and development 2nd edition |
| topic | bacteria L. acidophilus silver nanoparticles cancer bacteriocins TEM protein target antibiotic resistance bacterial pathogens ESBLs gold nanoparticles nano-therapeutics p-BthTX-I p-Bth multidrug-resistant bacteria antimicrobial peptide dendrimers PLpro SARS-CoV-2 COVID-19 antimicrobial resistance aminoglycosides kanamycin chemical modification mode of action translation inhibition thioureidophosphonates silver nanocomposites antibacterial bactericidal antifouling antibiofilm molecular docking colistin-resistant Escherichia coli lipopolysaccharide Trichoplusia ni cecropin bacterial resistance methicillin-resistant S. aureus (MRSA) multi drug resistant (MDR) bacteria Cannabis sativa phytocannabinoids (PCs) endocannabinois (ECs) synthetic cannabinoids (SCs) synthetic procedures cannabichromene (CBC) cannabigerol (CBG) cannabidiol (CBC) heterocycles five-membered heterocycles antibiotics antibacterials nitrogen heterocycles oxygen heterocycles sulfur heterocycles biological activity drug design drug discovery ZnONPs biosynthesis characterization antimicrobial applications antimicrobial mechanisms co-crystals crystal engineering flavonoids antimicrobials HP1043 essential transcription factor Helicobacter pylori thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general |
| topic_facet | bacteria L. acidophilus silver nanoparticles cancer bacteriocins TEM protein target antibiotic resistance bacterial pathogens ESBLs gold nanoparticles nano-therapeutics p-BthTX-I p-Bth multidrug-resistant bacteria antimicrobial peptide dendrimers PLpro SARS-CoV-2 COVID-19 antimicrobial resistance aminoglycosides kanamycin chemical modification mode of action translation inhibition thioureidophosphonates silver nanocomposites antibacterial bactericidal antifouling antibiofilm molecular docking colistin-resistant Escherichia coli lipopolysaccharide Trichoplusia ni cecropin bacterial resistance methicillin-resistant S. aureus (MRSA) multi drug resistant (MDR) bacteria Cannabis sativa phytocannabinoids (PCs) endocannabinois (ECs) synthetic cannabinoids (SCs) synthetic procedures cannabichromene (CBC) cannabigerol (CBG) cannabidiol (CBC) heterocycles five-membered heterocycles antibiotics antibacterials nitrogen heterocycles oxygen heterocycles sulfur heterocycles biological activity drug design drug discovery ZnONPs biosynthesis characterization antimicrobial applications antimicrobial mechanisms co-crystals crystal engineering flavonoids antimicrobials HP1043 essential transcription factor Helicobacter pylori thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general |
| url | ONIX_20250812T110751_9783725840281_297 |